Statements (39)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:chemical_compound
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:Nutrilite_Daily
|
gptkbp:availability |
available as tablets
available as capsules available as powder |
gptkbp:composed_of |
synthesized in the body
|
gptkbp:discovered_by |
1950s
|
gptkbp:dissolved |
soluble in water
soluble in alcohol |
gptkbp:dosage_form |
600 mg per day
|
gptkbp:financial_performance |
stable at room temperature
|
gptkbp:function |
antioxidant
cofactor for mitochondrial bioenergetic enzymes |
https://www.w3.org/2000/01/rdf-schema#label |
alpha-lipoic acid
|
gptkbp:ingredients |
C8 H14 O2 S
|
gptkbp:interacts_with |
may interact with diabetes medications
may interact with chemotherapy drugs |
gptkbp:is_found_in |
gptkb:fungus
spinach potatoes broccoli red meat |
gptkbp:mass |
206.25 g/mol
|
gptkbp:products |
acetyl-lipoic acid
dihydrolipoic acid |
gptkbp:research |
studied for cardiovascular health
studied for neuroprotective effects studied for liver health studied for skin aging studied for weight loss effects |
gptkbp:safety_features |
generally recognized as safe (GRAS)
|
gptkbp:side_effect |
nausea
skin rash hypoglycemia |
gptkbp:social_structure |
thioctic acid
|
gptkbp:storage |
store in a cool, dry place
|
gptkbp:uses |
gptkb:product
treatment for diabetic neuropathy |